July 20, 2015 | The Israeli drug development company Chiasma announced that it raised $102 million in a NASDAQ IPO. The company sold 6.3 million shares at $16 a piece with a market cap of $562 million. Chiasma had raised $70 million previously in a private placement. Chiasma also recently submitted its request to begin marketing its treatment for acromegaly. Chiasma was founded in 2001 and is headquartered in Jerusalem.